ERGIC2
Basic information
Region (hg38): 12:29337352-29381189
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ERGIC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 1 | 0 |
Variants in ERGIC2
This is a list of pathogenic ClinVar variants found in the ERGIC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-29341166-T-C | not specified | Uncertain significance (Nov 04, 2022) | ||
12-29341182-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
12-29341211-A-G | not specified | Uncertain significance (Feb 13, 2025) | ||
12-29341738-T-C | not specified | Uncertain significance (Feb 07, 2023) | ||
12-29341745-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
12-29341768-C-T | not specified | Uncertain significance (Jan 19, 2025) | ||
12-29343140-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
12-29343170-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
12-29343260-G-T | not specified | Uncertain significance (Dec 28, 2023) | ||
12-29345454-C-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
12-29345484-T-C | not specified | Uncertain significance (Aug 14, 2023) | ||
12-29349091-T-C | not specified | Uncertain significance (Sep 13, 2023) | ||
12-29349118-T-C | not specified | Uncertain significance (Sep 01, 2024) | ||
12-29349121-T-A | not specified | Uncertain significance (Apr 09, 2024) | ||
12-29349135-T-G | not specified | Uncertain significance (Oct 27, 2021) | ||
12-29350061-G-C | not specified | Uncertain significance (Nov 10, 2024) | ||
12-29356418-T-C | not specified | Uncertain significance (Dec 09, 2024) | ||
12-29356470-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
12-29357644-G-A | not specified | Uncertain significance (Sep 26, 2022) | ||
12-29357645-T-C | not specified | Likely benign (Jul 14, 2021) | ||
12-29366888-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
12-29366947-T-A | not specified | Uncertain significance (Dec 01, 2022) | ||
12-29368259-C-A | not specified | Uncertain significance (Mar 14, 2025) | ||
12-29368265-T-C | not specified | Uncertain significance (Aug 10, 2021) | ||
12-29370115-T-C | not specified | Uncertain significance (Apr 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ERGIC2 | protein_coding | protein_coding | ENST00000360150 | 13 | 43838 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0135 | 0.985 | 124774 | 0 | 17 | 124791 | 0.0000681 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.07 | 152 | 194 | 0.785 | 0.00000927 | 2482 |
Missense in Polyphen | 30 | 53.544 | 0.56029 | 688 | ||
Synonymous | 0.689 | 54 | 60.8 | 0.888 | 0.00000285 | 678 |
Loss of Function | 2.82 | 7 | 20.9 | 0.334 | 9.67e-7 | 281 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000127 | 0.000125 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000113 | 0.000111 |
Finnish | 0.0000465 | 0.0000464 |
European (Non-Finnish) | 0.0000905 | 0.0000883 |
Middle Eastern | 0.000113 | 0.000111 |
South Asian | 0.00 | 0.00 |
Other | 0.000168 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Possible role in transport between endoplasmic reticulum and Golgi. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.0850
Intolerance Scores
- loftool
- 0.421
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.07
Haploinsufficiency Scores
- pHI
- 0.841
- hipred
- Y
- hipred_score
- 0.517
- ghis
- 0.625
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.284
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ergic2
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
- Cellular component
- nucleus;nucleolus;cytoplasm;endoplasmic reticulum;membrane;COPII-coated ER to Golgi transport vesicle;integral component of Golgi membrane;integral component of endoplasmic reticulum membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;intracellular membrane-bounded organelle
- Molecular function
- protein binding